Endpoints News 2026-02-21 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Endpoints News 2026-02-14 Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
FierceBiotech 2026-02-13 With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech 2026-02-12 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
FierceBiotech 2026-02-11 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale